GAM
AMED

Gotham Asset Management’s Amedisys AMED Stock Holding History

Gotham Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-342,392
Closed -$33.7M – 1688
2025
Q2 		$33.7M Buy
342,392
+50,328
+17% +$4.76M 0.2% 49
2025
Q1 		$27.1M Buy
292,064
+45,146
+18% +$4.16M 0.23% 33
2024
Q4 		$22.4M Buy
246,918
+107,720
+77% +$9.89M 0.21% 57
2024
Q3 		$13.4M Buy
139,198
+14,139
+11% +$1.38M 0.14% 178
2024
Q2 		$11.5M Buy
125,059
+42,098
+51% +$3.91M 0.15% 136
2024
Q1 		$7.65M Buy
82,961
+16,553
+25% +$1.55M 0.12% 226
2023
Q4 		$6.31M Sell
66,408
-9,128
-12% -$853K 0.12% 218
2023
Q3 		$7.06M Buy
75,536
+4,430
+6% +$409K 0.15% 147
2023
Q2 		$6.5M Buy
71,106
+38,305
+117% +$3.14M 0.14% 153
2023
Q1 		$2.41M Buy
32,801
+11,775
+56% +$1.02M 0.06% 451
2022
Q4 		$1.76M Sell
21,026
-2,297
-10% -$207K 0.05% 469
2022
Q3 		$2.26M Buy
23,323
+6,035
+35% +$720K 0.07% 356
2022
Q2 		$1.82M Buy
17,288
+1,604
+10% +$205K 0.06% 401
2022
Q1 		$2.7M Buy
15,684
+4,516
+40% +$675K 0.08% 287
2021
Q4 		$1.81M Buy
11,168
+381
+4% +$61.2K 0.06% 376
2021
Q3 		$1.61M Buy
10,787
+737
+7% +$153K 0.07% 359
2021
Q2 		$2.46M Buy
10,050
+6,279
+167% +$1.65M 0.1% 263
2021
Q1 		$999K Buy
3,771
+204
+6% +$57.5K 0.04% 474
2020
Q4 		$1.05M Hold
3,567
– – 0.03% 528
2020
Q3 		$843K Hold
3,567
– – 0.03% 588
2020
Q2 		$708K Sell
3,567
-55
-2% -$10.3K 0.02% 661
2020
Q1 		$665K Hold
3,622
– – 0.02% 654
2019
Q4 		$605K Sell
3,622
-2,458
-40% -$366K 0.01% 749
2019
Q3 		$797K Sell
6,080
-9,863
-62% -$1.28M 0.01% 638
2019
Q2 		$1.94M Buy
15,943
+6,250
+64% +$742K 0.03% 511
2019
Q1 		$1.2M Buy
9,693
+3,188
+49% +$400K 0.02% 611
2018
Q4 		$762K Buy
+6,505
New +$767K 0.01% 686
2018
Q1 		– Sell
-108,718
Closed -$5.73M – 936
2017
Q4 		$5.73M Buy
108,718
+101,470
+1,400% +$5.35M 0.08% 327
2017
Q3 		$406K Buy
+7,248
New +$383K 0.01% 737
2016
Q4 		– Sell
-5,938
Closed -$282K – 936
2016
Q3 		$282K Sell
5,938
-45,627
-88% -$2.28M ﹤0.01% 797
2016
Q2 		$2.6M Sell
51,565
-178,138
-78% -$8.99M 0.03% 486
2016
Q1 		$11.1M Sell
229,703
-116,209
-34% -$4.48M 0.12% 280
2015
Q4 		$13.6M Buy
345,912
+208,525
+152% +$8.34M 0.15% 217
2015
Q3 		$5.22M Sell
137,387
-258,006
-65% -$10.9M 0.05% 416
2015
Q2 		$15.7M Buy
395,393
+355,859
+900% +$11.1M 0.13% 243
2015
Q1 		$1.06M Buy
39,534
+16,185
+69% +$457K 0.01% 589
2014
Q4 		$685K Buy
+23,349
New +$577K 0.01% 683

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gotham Asset Management's AMED Position: Q3 2025 in Review

Gotham Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 342,392 shares — an estimated $33.7M sold.

Gotham Asset Management first reported a position in AMED in Q4 2014 and held it in 37 quarters. The position peaked at $33.7M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Gotham Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Gotham Asset Management sold 342,392 Amedisys shares in Q3 2025, an estimated $33.7M.
  • Gotham Asset Management first reported a position in Amedisys in Q4 2014 and held it in 37 quarters.
  • Gotham Asset Management's Amedisys position peaked at $33.7M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Gotham Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.